The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

Cardiovascular risks associated with gender and aging

JL Rodgers, J Jones, SI Bolleddu… - Journal of …, 2019 - mdpi.com
The aging and elderly population are particularly susceptible to cardiovascular disease. Age
is an independent risk factor for cardiovascular disease (CVD) in adults, but these risks are …

Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome

A Haider, S Bengs, J Luu, E Osto… - European heart …, 2020 - academic.oup.com
Although health disparities in women presenting with acute coronary syndrome (ACS) have
received growing attention in recent years, clinical outcomes from ACS are still worse for …

Cardiovascular disease and the female disadvantage

M Woodward - International journal of environmental research and …, 2019 - mdpi.com
Age-standardised rates of cardiovascular disease (CVD) are substantially higher in men
than women. This explains why CVD has traditionally been seen as a “man's problem” …

Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease

F Rodriguez, DJ Maron, JW Knowles, SS Virani… - JAMA …, 2019 - jamanetwork.com
Importance Statins decrease mortality in those with atherosclerotic cardiovascular disease
(ASCVD), but statin adherence remains suboptimal. Objective To determine the association …

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

JE Roeters van Lennep, LS Tokgözoğlu… - European heart …, 2023 - academic.oup.com
Cardiovascular disease is the leading cause of death in women and men globally, with most
due to atherosclerotic cardiovascular disease (ASCVD). Despite progress during the last 30 …

Sex differences in the use of statins in community practice: patient and provider assessment of lipid management registry

MG Nanna, TY Wang, Q Xiang… - … Quality and Outcomes, 2019 - Am Heart Assoc
Background: Female patients have historically received less aggressive lipid management
than male patients. Contemporary care patterns and the potential causes for these …

Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta‐analysis

M Zhao, M Woodward, I Vaartjes… - Journal of the …, 2020 - Am Heart Assoc
Background Sex differences in the management of cardiovascular disease have been
reported in secondary care. We conducted a systematic review with meta‐analysis of …

A life-course approach to tackling noncommunicable diseases in women

C Carcel, S Haupt, C Arnott, ML Yap, A Henry… - Nature Medicine, 2024 - nature.com
Women's health has been critically underserved by a failure to look beyond women's sexual
and reproductive systems to adequately consider their broader health needs. In almost …

Cardiovascular disease screening in women: leveraging artificial intelligence and digital tools

DA Adedinsewo, AW Pollak, SD Phillips… - Circulation …, 2022 - Am Heart Assoc
Cardiovascular disease remains the leading cause of death in women. Given accumulating
evidence on sex-and gender-based differences in cardiovascular disease development and …